Tenax Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, TENX, Tenax Therapeutics Inc, priceseries

Tenax Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.56
Close
0.55
High
0.59
Low
0.55
Previous Close
0.56
Daily Price Gain
-0.01
YTD High
1.46
YTD High Date
Jan 4, 2022
YTD Low
0.55
YTD Low Date
Feb 28, 2022
YTD Price Change
-0.56
YTD Gain
-50.26%
52 Week High
2.68
52 Week High Date
Mar 16, 2021
52 Week Low
0.55
52 Week Low Date
Feb 28, 2022
52 Week Price Change
-1.57
52 Week Gain
-73.96%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 27. 2017
11.62
Jul 3. 2017
12.41
4 Trading Days
6.80%
Link
LONG
Mar 6. 2019
1.63
Mar 11. 2019
1.72
3 Trading Days
5.52%
Link
LONG
Mar 14. 2019
1.63
Mar 22. 2019
1.88
6 Trading Days
15.54%
Link
LONG
Dec 26. 2019
1.23
Jan 7. 2020
1.29
7 Trading Days
5.24%
Link
LONG
May 15. 2020
0.98
Jun 4. 2020
1.39
13 Trading Days
41.42%
Link
LONG
Jul 14. 2020
0.98
Aug 6. 2020
1.26
17 Trading Days
28.73%
Link
LONG
Sep 11. 2020
1.46
Sep 23. 2020
1.65
8 Trading Days
12.95%
Link
LONG
Jan 14. 2021
1.78
Jan 28. 2021
2.36
9 Trading Days
32.51%
Link
LONG
Sep 24. 2021
1.35
Oct 15. 2021
1.76
15 Trading Days
30.34%
Link
LONG
Jan 3. 2022
1.11
Jan 4. 2022
1.28
1 Trading Days
15.72%
Link
Company Information
Stock Symbol
TENX
Exchange
NasdaqCM
Company URL
http://www.tenaxthera.com
Company Phone
919-806-4414
CEO
Michael B. Jebsen
Headquarters
North Carolina
Business Address
ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE, NC 27560
Sector
-
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000034956
About

Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing and commercializing products for the critical care market. Its objective is to identify, develop, and commercialize novel therapeutic products for disease indications that represent significant areas of clinical need and commercial opportunity. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Description

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company offers Wundecyte, a wound-healing gel. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading